Aortic Stenosis Treatment Market Segmentation:
End user Segment Analysis
Hospitals dominate the aortic stenosis treatment market and is poised to hold the market share of 66.7% by 2035. The segment is fueled due to their surgical infrastructure, access to trained cardiac specialists, and set up reimbursement routes. Cardiac specialty centers are growing, particularly in urban Europe and Asia, but fall short of the procedural capability of North American or EU hospital systems. Moreover, hospitals are supported by care pathways and intensive post-operative care units that are essential for high-risk aortic stenosis patients. Their capacity to treat complications and provide multidisciplinary cardiac care also supports their leadership in the market.
Treatment Modality Segment Analysis
The TAVR minimally invasive procedure leads the segment and is expected to hold the share of 65.3% by 2035. The segment is fueled primarily by the growth of TAVR indications to intermediate and low-risk patients, aided by clinical results demonstrating lower morbidity, decreased length of stay, and faster recovery. The Centers for Medicare & Medicaid Services (CMS) supports complete reimbursement for TAVR procedures, making expanded access available in the U.S. Moreover, data from NIH studies show that TAVR use has increased in the last decade, replacing SAVR in most elderly patients.
Valve Mechanism Segment Analysis
Balloon expandable valves are currently dominating the market, holding 55% of the share by 2035. Recently, balloon-expandable valves from Edwards Lifesciences have showcased robust clinical outcomes. The growth of the segment is also driven by the high familiarity of cardiologists and surgeons with balloon-expandable technology. These factors make it a default choice for healthcare practitioners. These valves have secured approvals for usage in the high intermediate in various countries. Additionally, such valves are useful as they have established outcomes and trust from many physicians.
Our in-depth analysis of the global aortic stenosis treatment market includes the following segments:
|
Segment |
Subsegments |
|
Treatment Modality |
|
|
Implantation Procedure |
|
|
Valve Mechanism |
|
|
Product Type |
|
|
End user |
|
|
Patient risk/ Indication |
|
